Penserra Capital Management LLC Nuvation Bio Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.24 - $5.85 $336 - $608	-104 Reduced 1.48%	6,914 $22,000
Q1 2022 May 13, 2022	SELL	$4.6 - $8.83 $15,451 - $29,659	-3,359 Reduced 32.37%	7,018 $36,000
Q4 2021 Feb 15, 2022	SELL	$7.75 - $10.05 $46,569 - $60,390	-6,009 Reduced 36.67%	10,377 $88,000
Q3 2021 Nov 15, 2021	SELL	$7.78 - $10.0 $163,177 - $209,740	-20,974 Reduced 56.14%	16,386 $162,000
Q2 2021 Aug 12, 2021	BUY	$9.22 - $14.48 $344,459 - $540,972	37,360 New	37,360 $347,000

152

123M

9.7K

6.5K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $480M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.